KANG [iKang Healthcare] SC 13G: (Name of Issuer) Class A Common Stock (Title

[(Name of Issuer) Class A Common Stock (Title of Class of Securities) (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]

KANG [iKang Healthcare] 6-K: Press Release iKang Announces Equity Investment in New

[Press Release iKang Announces Equity Investment in New China Life Insurance Health Investment Management Co., Ltd. BEIJING, February 2, 2016 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), China’s largest private preventive healthcare services provider, today announced that it has completed a strategic investment in New China Life Insurance Health Investment Management Co., Ltd. (“NCI Health”). After] [IKANG HEALTHCARE GROUP, INC. Yang Chen Chief Financial Officer]

KANG [iKang Healthcare] SC 13D/A: (Original Filing)

[Execution Version AMENDED AND RESTATED THIS Agreement Chairman TIFL SMI Chairman Holding Companies Chairman Parties FountainVest 天津君联赟鹏企业管理咨询合伙企业(有限合伙) Sponsors Party Parties WHEREAS, Original Consortium Agreement Transaction Target Exchange Act Holdco WHEREAS, (a) in connection with the Transaction, the Parties propose to form a new company (“ WHEREAS, Schedule A Proposal Target Board WHEREAS, in accordance with the terms of this Agreement,] []

KANG [iKang Healthcare] SC 13D/A: Execution Version AMENDED AND RESTATED THIS Agreement Chairman

[Execution Version AMENDED AND RESTATED THIS Agreement Chairman TIFL SMI Chairman Holding Companies Chairman Parties FountainVest 天津君联赟鹏企业管理咨询合伙企业(有限合伙) Sponsors Party Parties WHEREAS, Original Consortium Agreement Transaction Target Exchange Act Holdco WHEREAS, (a) in connection with the Transaction, the Parties propose to form a new company (“ WHEREAS, Schedule A Proposal Target Board WHEREAS, in accordance with the terms of this Agreement,] []

KANG [iKang Healthcare] 6-K: (Original Filing)

[Press Release iKang Announces Acquisition of Shaanxi INLUNG Health Management BEIJING, December 22, 2015 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), China’s largest private preventive healthcare services provider, today announced that it has acquired 70% equity interest of Xi’an iKang Health Management, which has 100% ownership in three medical centers under the brand name of Xi’an] [IKANG HEALTHCARE GROUP, INC. Yang Chen]

KANG [iKang Healthcare] 6-K: Press Release iKang Announces Acquisition of Shaanxi INLUNG

[Press Release iKang Announces Acquisition of Shaanxi INLUNG Health Management BEIJING, December 22, 2015 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), China’s largest private preventive healthcare services provider, today announced that it has acquired 70% equity interest of Xi’an iKang Health Management, which has 100% ownership in three medical centers under the brand name of Xi’an] [IKANG HEALTHCARE GROUP, INC. Yang Chen]

KANG [iKang Healthcare] SC 13G/A: (Original Filing)

[SCHEDULE 13G/A (Rule 13d-102) TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED 1) ( AMENDMENT iKang Healthcare Group, Inc. ( NAME OF ISSUER ) ADR (Title of Class of Securities) 45174L108 (CUSIP Number) November 30, 2015 (Date of Event Which Requires Filing of this Statement) X Rule 13d-1 (b) Rule 13d-1 (c) Rule 13d-1 (d) CUSIP No. 45174L108]

KANG [iKang Healthcare] SC 13G/A: SCHEDULE 13G/A (Rule 13d-102) TO RULES 13d-1(b), (c),

[SCHEDULE 13G/A (Rule 13d-102) TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED 1) ( AMENDMENT iKang Healthcare Group, Inc. ( NAME OF ISSUER ) ADR (Title of Class of Securities) 45174L108 (CUSIP Number) November 30, 2015 (Date of Event Which Requires Filing of this Statement) X Rule 13d-1 (b) Rule 13d-1 (c) Rule 13d-1 (d) CUSIP No. 45174L108]

Skip to toolbar